Literature DB >> 6802333

Propranolol, oxprenolol, and sclerosing peritonitis.

J H Marigold, R E Pounder, J Pemberton, R P Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6802333      PMCID： PMC1496302          DOI： 10.1136/bmj.284.6319.870

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Untoward effects associated with practolol administration: oculomucocutaneous syndrome.

Authors:  P Wright
Journal:  Br Med J       Date:  1975-03-15

2.  Practolol peritonitis. A study of 16 cases and a survey of small bowel function in patients taking beta adrenergic blockers.

Authors:  A J Marshall; H Baddeley; D W Barritt; J D Davies; R E Lee; T S Low-Beer; A E Read
Journal:  Q J Med       Date:  1977-01

3.  Sclerosing peritonitis and propranolol.

Authors:  S Ahmad
Journal:  Chest       Date:  1981-03       Impact factor: 9.410

4.  Sclerosing peritonitis and propranolol.

Authors:  R F Harty
Journal:  Arch Intern Med       Date:  1978-09
  4 in total
  5 in total

1.  Sclerosing encapsulating peritonitis.

Authors:  M Wanic-Kossowska; A Grzegorzewska; H Płotast
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 2.  Review of general surgery 1982.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1983-07       Impact factor: 2.401

3.  Encapsulating peritoneal sclerosis in the new millennium: a national cohort study.

Authors:  Michaela C Brown; Keith Simpson; Jan J Kerssens; Robert A Mactier
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

4.  Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea.

Authors:  Beom Seok Kim; Hoon Young Choi; Dong-Ryeol Ryu; Tae Hyun Yoo; Hyeong Cheon Park; Shin Wook Kang; Kyu Hun Choi; Sung Kyu Ha; Dae Suk Han; Ho Yung Lee
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

Review 5.  Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options.

Authors:  Rajesh M Jagirdar; Andreas Bozikas; Sotirios G Zarogiannis; Maria Bartosova; Claus Peter Schmitt; Vassilios Liakopoulos
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.